Literature DB >> 8467366

Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro.

B Driessen1, W Reimann, H Giertz.   

Abstract

1. The centrally acting analgesic, tramadol, has low affinity for opioid receptors and therefore presumably other mechanisms of analgesic action. Neurotransmitter release and uptake experiments were used to characterize the effects of tramadol on the central noradrenergic and dopaminergic systems. 2. Tramadol inhibited the uptake of [3H]-noradrenaline into purified rat hypothalamic synaptosomes with an IC50 of 2.8 microM; the (-)-enantiomer was about ten times more potent than the (+)-enantiomer. Results with the principal metabolite O-desmethyltramadol were very similar. Inhibition of dopamine uptake into purified rabbit caudate nucleus synaptosomes was very weak with 62% inhibition of 100 microM. 3. Rat occipital cortex slices were preincubated with [3H]-noradrenaline and rabbit caudate nucleus slices with [3H]-dopamine, then superfused and stimulated electrically. Tramadol, 1 and 10 microM, enhanced the stimulation-evoked [3H]-noradrenaline overflow by 25 and 69%, respectively; the (-)-enantiomer was more potent than the racemate or the (+)-enantiomer. Tramadol, 10 microM, had no effect on dopamine release. 4. The effects of tramadol on the stimulation-evoked [3H]-noradrenaline release were abolished when uptake sites were already blocked by a high concentration of cocaine. 5. The metabolite O-desmethyltramadol showed a slight facilitation of the stimulation-evoked noradrenaline release; the effect was more pronounced in the presence of a high concentration of naloxone. In the presence of cocaine, inhibition of the release was observed similar to the effect of morphine but less potent. 6. The results show that tramadol blocks noradrenaline uptake with selectivity as compared to dopamine uptake. The interaction with the noradrenaline transporter is stereoselective. The principal metabolite O-desmethyltramadol shows in addition to noradrenaline uptake inhibition, opioid inhibition of noradrenaline release.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8467366      PMCID: PMC1908052          DOI: 10.1111/j.1476-5381.1993.tb12882.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Is drug inhibition of dopamine uptake a misinterpretation of in vitro experiments?

Authors:  P A Bauman; L Maitre
Journal:  Nature       Date:  1976 Dec 23-30       Impact factor: 49.962

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Alpha-receptor-mediated modulation of transmitter release from central noradrenergic neurones.

Authors:  K Starke; H Montel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

Review 4.  Presynaptic receptors.

Authors:  K Starke
Journal:  Annu Rev Pharmacol Toxicol       Date:  1981       Impact factor: 13.820

5.  Effect of extracellular dopamine on the release of dopamine in the rabbit caudate nucleus: evidence for a dopaminergic feedback inhibition.

Authors:  W Reimann; A Zumstein; R Jackisch; K Starke; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-01       Impact factor: 3.000

6.  Influence of morphine and naloxone on the release of noradrenaline from rat brain cortex slices.

Authors:  H Montel; K Starke; F Weber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

7.  Uptake mechanisms for neurotransmitter amines.

Authors:  L L Iversen
Journal:  Biochem Pharmacol       Date:  1974-07-15       Impact factor: 5.858

8.  Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro.

Authors:  K Starke; W Reimann; A Zumstein; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

9.  Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain.

Authors:  B K Koe
Journal:  J Pharmacol Exp Ther       Date:  1976-12       Impact factor: 4.030

10.  Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain.

Authors:  J Glowinski; L L Iversen
Journal:  J Neurochem       Date:  1966-08       Impact factor: 5.372

View more
  39 in total

1.  µ-Opioid receptor activation by tramadol and O-desmethyltramadol (M1).

Authors:  Kouichiro Minami; Yuka Sudo; Kanako Miyano; Robert S Murphy; Yasuhito Uezono
Journal:  J Anesth       Date:  2014-11-14       Impact factor: 2.078

2.  Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers.

Authors:  Miriam Z Mintzer; Ryan K Lanier; Michelle R Lofwall; George E Bigelow; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2010-06-09       Impact factor: 4.492

3.  Efficacy of preventive analgesia with tramadol or lornoxicam for percutaneous nephrolithotomy: a prospective, randomized, double-blind, placebo-controlled study.

Authors:  Kenan Kaygusuz; Gokhan Gokce; Iclal Ozdemir Kol; Semih Ayan; Sinan Gursoy
Journal:  Curr Ther Res Clin Exp       Date:  2007-07

4.  Potentiating effect of tramadol on methamphetamine-induced behavioral sensitization in mice.

Authors:  Jian-Hui Liang; Keng Wang; Hong-Lei Sun; Rong Han
Journal:  Psychopharmacology (Berl)       Date:  2006-01-24       Impact factor: 4.530

Review 5.  Opioid metabolism.

Authors:  Howard S Smith
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

6.  Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patients.

Authors:  Janet K Coller; Jennifer R Michalakas; Heather M James; Aaron L Farquharson; Joel Colvill; Jason M White; Andrew A Somogyi
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

7.  Ticlopidine inhibits both O-demethylation and renal clearance of tramadol, increasing the exposure to it, but itraconazole has no marked effect on the ticlopidine-tramadol interaction.

Authors:  Nora M Hagelberg; Tuukka Saarikoski; Teijo I Saari; Mikko Neuvonen; Pertti J Neuvonen; Miia Turpeinen; Mika Scheinin; Kari Laine; Klaus T Olkkola
Journal:  Eur J Clin Pharmacol       Date:  2012-10-26       Impact factor: 2.953

8.  Tramadol-induced seizurogenic effect: a possible role of opioid-dependent histamine H1 receptor activation-linked mechanism.

Authors:  Ashish K Rehni; Thakur Gurjeet Singh; Nirmal Singh; Sandeep Arora
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-10       Impact factor: 3.000

9.  Evaluation of antidepressant activity of tramadol in mice.

Authors:  Vandana Tayal; Bhupinder Singh Kalra; Shalini Chawla
Journal:  Indian J Pharmacol       Date:  2008-06       Impact factor: 1.200

10.  Antidepressant-like activity of tramadol in mice.

Authors:  Bhupinder Singh Kalra; Vandana Tayal; Shalini Chawla
Journal:  Indian J Psychiatry       Date:  2008-01       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.